fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd

Updated on February 20, 2020

Stock/Share Code - APLLTD

Alembic Pharmaceuticals is a vertically integrated pharmaceutical company committed to deliver high-quality healthcare access to patients across the world.(Source : 201903 Annual Report Page No: 2)

Below is the details of APLLTD Alembic Pharmaceuticals Ltd

Market Cap₹10,403 Cr.
Current Price ₹557.6 as on 10 Dec 19
52 Week High / Low Price₹638 / ₹435.1
Face Value₹2
Stock P/E15.53
Book Value₹159.45
Dividend Yield1.00 %
ROCE23.58 %
ROE24.82 %
Sales Growth (3yrs)6.75 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has a good return on equity (ROE) track record: 3 Years ROE 23.58% Company has been maintaining a healthy dividend payout of 17.45%
Cons: Company might be capitalizing the interest cost

Alembic Pharmaceuticals Ltd Price Chart

Alembic Pharmaceuticals Ltd Price Chart

Alembic Pharmaceuticals Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹170.05 24.93 ₹107,934.08 Cr. 0.61 ₹1,064.09 Cr. 57.62 17.09 8123.35 11.19
2. Dr Reddy's Labs ₹2,897.5 17.68 ₹48,412.38 Cr. 0.69 ₹1,106.8 Cr. 113.54 26.07 4812.80 12.42
3. Cipla ₹453.05 22.78 ₹37,626.53 Cr. 0.64 ₹474.5 Cr. 25.85 9.57 4395.78 10.94
4. Piramal Enterp. ₹1,611.6 17.30 ₹36,008.74 Cr. 1.43 ₹554.69 Cr. 17.26 14.61 3603.56 9.42
5. Biocon ₹289.65 43.30 ₹33,798 Cr. 0.18 ₹215.7 Cr. -24.60 19.02 1572.20 13.39
6. Torrent Pharma. ₹13.65 37.89 ₹32,128.11 Cr. 0.90 ₹244 Cr. 36.31 5.86 2005.00 12.66
7. Aurobindo Pharma ₹432.55 9.99 ₹26,361.38 Cr. 0.56 ₹639.86 Cr. 2.69 17.87 5600.47 18.45
8. Alembic Pharma ₹49.2 15.53 ₹10,403.32 Cr. 1.00 ₹268.69 Cr. 7.02 3.60 1134.90 23.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Alembic Pharmaceuticals Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
Sales8056475907627558388111,0959058498971,135
YOY Sales Growth %-9.79%9.98%-15.38%-8.93%-6.2%29.55%37.5%43.76%19.84%1.25%10.51%3.6%
Expenses609549503585594631640746700696672774
Material Cost %27.96%30.38%28.49%30.87%29.68%31.64%29.33%24.85%30.27%25.45%26.25%24.41%
Employee Cost %17.89%20.17%25.64%20.01%18.43%16.68%18.78%15.44%20.33%21.08%21.8%17.78%
Operating Profit1969887177160207172349205153225361
OPM %24%15%15%23%21%25%21%32%23%18%25%32%
Other Income010800023130
Interest011011155457
Depreciation222222262628252627273233
Profit before tax1747664159134179145320177122191322
Tax %21%22%21%23%21%19%22%22%22%12%19%17%
Net Profit1385951122105144114251139108155269
EPS in Rs7.313.142.696.485.577.656.0513.327.355.718.2314.25
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales1,1651,3741,4931,8442,0193,0092,9862,9453,6603,785
Sales Growth %%17.97%8.61%23.53%9.5%49.04%-0.77%-1.36%24.28%%
Expenses1,0091,1661,2491,4851,6112,0262,3532,3132,7822,841
Material Cost %47.97%45.96%44.03%38.69%35.38%26.98%29.68%30.31%27.32%%
Manufacturing Cost %5.7%6.13%4.9%5.52%5.46%9.08%9.55%9.22%8.81%%
Employee Cost %12.81%12.26%12.98%13.26%14.69%15.07%17.67%19.79%18.7%%
Other Cost %20.15%20.47%21.75%23.06%24.27%16.22%21.9%19.21%21.16%%
Operating Profit156209244359408983633633879944
OPM %13%15%16%19%20%33%21%21%24%25%
Other Income413134373768
Interest2838241034321520
Depreciation30343540447283102106119
Profit before tax102150198312363914550535765812
Tax %20%20%21%24%21%24%22%21%20%
Net Profit82121157238287699431422611670
EPS in Rs6.177.9312.1314.4937.0722.8522.3932.4235.54
Dividend Payout %7%22%30%24%23%11%18%18%17%

Compounded Sales Growth

  • 5 Years:: 14.70%
  • 3 Years:: 6.75%
  • TTM:: 8.15%

Compounded Profit Growth

  • 5 Years:: 20.65%
  • 3 Years:: -4.47%
  • TTM:: 9.09%

Return on Equity

  • 5 Years:: 5.08%
  • 3 Years:: -5.30%
  • 1 Year:: -10.62%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital38383838383838383838
Equity Capital1137.737.737.737.737.737.737.737.737.7
Reserves2393234225927961,4931,8302,1572,6752,968
Borrowings328353187109194086221,0591,183
Other Liabilities2632963694405006756829368731,256
Trade Payables131.75181.93234.25281.9316.45499.76430.11601.98529.91596.28
Total Liabilities8401,0101,0151,1791,5272,2052,5583,7524,6455,445
Fixed Assets2722683443974896977999181,0851,169
Gross Block433.52462.9572.46665.06802.851082.44948.641162.611435.06
Accumulated Depreciation161.53195.08228.24268.1314.17385.19149.63244.31349.62
CWIP2658322183923487411,1071,372
Investments333333337103299506606
Other Assets5386816357289221,3781,3081,7941,9462,298
Inventories219.23258.74266.83310.78382.48533.72574.62669.93891.411079.64
Trade receivables201.97186.83232.38260.56337.94371.5467.41621.66539.75878.87
Cash Equivalents1.2825.734.255.344.41284.817.2115.63150.829.06
Loans n Advances109.36174.3496.06109.49132.4158.39222.01442.33349.630
Other Assets etc6.5534.9935.941.6465.0329.9636.5344.3714.31310.47
Total Assets8401,0101,0151,1791,5272,2052,5583,7524,6455,445

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity105125274263180848327305809
Profit from operations155.05217.7255.44374.36397.71986.96634.58617.14859.12
Working Capital Changes-33.32-60.8157.17-43.52-148.5356.64-189.44-188.46107.37
Taxes paid-17.16-31.47-38.29-67.66-69.1-196.08-117.98-124.13-157.69
Cash from Investing Activity-57-56-67-111-199-292-511-794-754
Fixed Assets Purchased-62.54-61.260-81.96-200.67-289.76-453.09-608.76-565.96
Fixed Assets Sold0.190.050.550.10.050.136.5414.41.28
Capital WIP00-85.97000000
Investments purchased000-29.970-4.13-65.5800
Cash from Financing Activity-47-45-229-15118-276-9649880
Proceeds from Shares1100000000
Proceeds from Borrowings2.2366.2800124.3800613.04825.05
Repayment of Borrowings-32.75-52.46-170.09-85.43-37.2-192.87-0.4800
Interest Paid-27.43-37.21-28.8-10.99-4.33-3.84-3.21-24.84-66.8
Dividends Paid0-21.65-30.36-54.58-65.5-78.7-90.1-90.76-90.9
Net Cash Flow124-211-1280-2809135

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %28%33%47%41%72%32%23%24%
Debtor Days635057526145577754
Inventory Turnover5.755.686.385.826.575.394.734.69

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Alembic Pharmaceuticals Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.